Ascopharm is a developer and provider of high quality nutritional supplements, OTC drugs, minerals, vitamins and cosmetic products. Adiuva Capital acquired the company, which was founded in 1977, as part of a succession from Karl-Heinz Oppermann.
From its headquarters in Wernigerode, Germany, Ascopharm supplies over 200,000 regular customers. To ensure the highest product quality, all Ascopharm products are manufactured and tested according to GMP guidelines. The company will be headed by Jens Lafrenz and Hannelore Hütcher.
Adiuva Capital will support Ascopharm in expanding the product portfolio, developing the B2B part of the business, and strengthening the online activities.